All treatments
Treatment
Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Effects of extensive Weight loss on Insulin resistance and Lipid-kinetics in people with obesity and fatty liver Disease
This study looks at how a weight-loss drug, Wegovy, affects fat in the blood and liver in people with obesity and fatty liver disease. Researchers want to see if losing weight helps improve these conditions.
For: Obesity, Non-alcoholic Fatty Liver DiseaseDenmark - AuthorisedTherapeutic use (Phase IV)
A neuropsychobiological approach to optimize patient selection for GLP-1-based pharmacotherapy for weight management across the binge eating spectrum
This study looks at how a weight loss injection, Wegovy, affects people with obesity, especially those who also experience binge eating. Researchers want to see changes in weight and binge eating habits after six months of treatment. It's investigating if certain body and brain signals can help pick the best candidates for this treatment.
For: obesityBelgium